References
- Kantarjian H M, Talpaz M, O'Brien S G, Garcia-Manero G, Verstovse K S, Giles F, et al. High dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome positive chronic phase myeloid leukaemia. Blood 2004; 103: 2873–2878
- O'Brien S G, Guilhot F, Larson R A, Gathmann I, Baccarani M, Cervantes F, et al. Imatinib compared with interferon and low dose cytarabine for newly diagnosed chronic phase chronic myeloid leukaemia. N Eng J Med 2003; 348: 994–1004
- Kantarjian H M, Talpaz M, O'Brien S G, Smith T L, Giles F J, Faderl S, et al. Imatinib mesylate for Philadelphia chromosome positive chronic phase myeloid leukaemia after failure of interferon alpha: follow-up results. Clin Cancer Res 2002; 8: 2177–2187
- Kantarjian H M, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorta-Passerini C, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukaemia. N Eng J Med 2002; 346: 645–652
- Druker B J, Talpaz M, Resta D J, Peng B, Buchdunger E, Ford J M, et al. Efficacy and safety of a specific inhibitor of the BCR-SBL tyrosine kinase in chronic myeloid leukaemia. N Eng J Med 2001; 344: 1031–1037
- Shah N P, Tran C, Lee F Y, Chen P, Norris D, Sawyers C L. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 2004; 305: 319–321
- Donato N J, Wu J Y, Staple Y J, Gallick G, Lin H, Arlinghaus R, et al. BCR-ABL indipendence and LYN kinase overexpression in chronic myelogenous leukaemia cells selected for resistance to STI571. Blood 2003; 101: 690–698
- Bergeron A, Bergot E, Vilela G, Ades L, Devergie A, Esperou H, et al. Hypersensitivity pneumonitis related to imatinib mesylate. J Clin Oncol 2002; 20: 4271–4272
- Isshiki I, Yamaguchi K, Okamoto S. Interstitial pneumonitis during imatinib therapy. Br J Haematol 2004; 125: 420
- Grimison P, Goldstein D, Schneeweiss J, Murray N. Corticosteroid-responsive interstitial pneumonitis related to imatinib mesylate with successful rechallenge, and potential causative mechanism. Intern Med J 2005; 35: 136–137